Skip to main content
. 2015 Dec 28;7(4):4326–4343. doi: 10.18632/oncotarget.6775

Figure 5. SLMP53-1 prevents the migration of HCT116p53+/+ and MDA-MB-231 cells.

Figure 5

(A) HCT116p53+/+ and (B) MDA-MB-231 confluent cells treated with 4 μM SLMP53-1 (or DMSO only) were observed at different time-points in the wound healing assay. (C) Effects of SLMP53-1 on the migration of HCT116p53+/+ (7 μM for 24 h) and MDA-MB-231 (16 μM for 8 h) cells analyzed by the chemotaxis assay; the migratory cells were quantified by fluorescence signal, setting as 1 cells treated with DMSO only; data are mean ± SEM (n = 3); values significantly different from DMSO only: ***p < 0.001.